report cover

mRNA Vaccine And Therapeutics Market, Global Outlook and Forecast 2023-2030

  • 12 October 2023
  • Life Sciences
  • 68 Pages
  • Report code : 24WT-7829272

mRNA Vaccine And Therapeutics and Forecast Market

1 Introduction to Research & Analysis Reports
1.1 mRNA Vaccine And Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global mRNA Vaccine And Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global mRNA Vaccine And Therapeutics Overall Market Size
2.1 Global mRNA Vaccine And Therapeutics Market Size: 2022 VS 2030
2.2 Global mRNA Vaccine And Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top mRNA Vaccine And Therapeutics Players in Global Market
3.2 Top Global mRNA Vaccine And Therapeutics Companies Ranked by Revenue
3.3 Global mRNA Vaccine And Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 mRNA Vaccine And Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies mRNA Vaccine And Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Vaccine And Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 mRNA Vaccine And Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 mRNA Vaccine And Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global mRNA Vaccine And Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Infectious Disease
4.1.3 Cancer
4.1.4 Others
4.2 By Type - Global mRNA Vaccine And Therapeutics Revenue & Forecasts
4.2.1 By Type - Global mRNA Vaccine And Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global mRNA Vaccine And Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global mRNA Vaccine And Therapeutics Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Research Institual
5.2 By Application - Global mRNA Vaccine And Therapeutics Revenue & Forecasts
5.2.1 By Application - Global mRNA Vaccine And Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global mRNA Vaccine And Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global mRNA Vaccine And Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global mRNA Vaccine And Therapeutics Revenue & Forecasts
6.2.1 By Region - Global mRNA Vaccine And Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global mRNA Vaccine And Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America mRNA Vaccine And Therapeutics Revenue, 2018-2030
6.3.2 US mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.3.3 Canada mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.3.4 Mexico mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe mRNA Vaccine And Therapeutics Revenue, 2018-2030
6.4.2 Germany mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.3 France mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.4 U.K. mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.5 Italy mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.6 Russia mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.4.8 Benelux mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia mRNA Vaccine And Therapeutics Revenue, 2018-2030
6.5.2 China mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.5.3 Japan mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.5.4 South Korea mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.5.6 India mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America mRNA Vaccine And Therapeutics Revenue, 2018-2030
6.6.2 Brazil mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.6.3 Argentina mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa mRNA Vaccine And Therapeutics Revenue, 2018-2030
6.7.2 Turkey mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.7.3 Israel mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia mRNA Vaccine And Therapeutics Market Size, 2018-2030
6.7.5 UAE mRNA Vaccine And Therapeutics Market Size, 2018-2030
7 mRNA Vaccine And Therapeutics Companies Profiles
7.1 Argos Therapeutics
7.1.1 Argos Therapeutics Company Summary
7.1.2 Argos Therapeutics Business Overview
7.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Major Product Offerings
7.1.4 Argos Therapeutics mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Argos Therapeutics Key News & Latest Developments
7.2 BioNTech
7.2.1 BioNTech Company Summary
7.2.2 BioNTech Business Overview
7.2.3 BioNTech mRNA Vaccine And Therapeutics Major Product Offerings
7.2.4 BioNTech mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.2.5 BioNTech Key News & Latest Developments
7.3 CureVac
7.3.1 CureVac Company Summary
7.3.2 CureVac Business Overview
7.3.3 CureVac mRNA Vaccine And Therapeutics Major Product Offerings
7.3.4 CureVac mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.3.5 CureVac Key News & Latest Developments
7.4 eTheRNA
7.4.1 eTheRNA Company Summary
7.4.2 eTheRNA Business Overview
7.4.3 eTheRNA mRNA Vaccine And Therapeutics Major Product Offerings
7.4.4 eTheRNA mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.4.5 eTheRNA Key News & Latest Developments
7.5 Ethris
7.5.1 Ethris Company Summary
7.5.2 Ethris Business Overview
7.5.3 Ethris mRNA Vaccine And Therapeutics Major Product Offerings
7.5.4 Ethris mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Ethris Key News & Latest Developments
7.6 In-Cell-Art
7.6.1 In-Cell-Art Company Summary
7.6.2 In-Cell-Art Business Overview
7.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Major Product Offerings
7.6.4 In-Cell-Art mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.6.5 In-Cell-Art Key News & Latest Developments
7.7 Moderna Therapeutics
7.7.1 Moderna Therapeutics Company Summary
7.7.2 Moderna Therapeutics Business Overview
7.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Major Product Offerings
7.7.4 Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.7.5 Moderna Therapeutics Key News & Latest Developments
7.8 Sangamo Therapeutics
7.8.1 Sangamo Therapeutics Company Summary
7.8.2 Sangamo Therapeutics Business Overview
7.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Major Product Offerings
7.8.4 Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.8.5 Sangamo Therapeutics Key News & Latest Developments
7.9 Tiba Biotechnology
7.9.1 Tiba Biotechnology Company Summary
7.9.2 Tiba Biotechnology Business Overview
7.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Major Product Offerings
7.9.4 Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.9.5 Tiba Biotechnology Key News & Latest Developments
7.10 Translate Bio
7.10.1 Translate Bio Company Summary
7.10.2 Translate Bio Business Overview
7.10.3 Translate Bio mRNA Vaccine And Therapeutics Major Product Offerings
7.10.4 Translate Bio mRNA Vaccine And Therapeutics Revenue in Global Market (2018-2023)
7.10.5 Translate Bio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. mRNA Vaccine And Therapeutics Market Opportunities & Trends in Global Market
Table 2. mRNA Vaccine And Therapeutics Market Drivers in Global Market
Table 3. mRNA Vaccine And Therapeutics Market Restraints in Global Market
Table 4. Key Players of mRNA Vaccine And Therapeutics in Global Market
Table 5. Top mRNA Vaccine And Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global mRNA Vaccine And Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global mRNA Vaccine And Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies mRNA Vaccine And Therapeutics Product Type
Table 9. List of Global Tier 1 mRNA Vaccine And Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Vaccine And Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - mRNA Vaccine And Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - mRNA Vaccine And Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - mRNA Vaccine And Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - mRNA Vaccine And Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global mRNA Vaccine And Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global mRNA Vaccine And Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. Argos Therapeutics Company Summary
Table 31. Argos Therapeutics mRNA Vaccine And Therapeutics Product Offerings
Table 32. Argos Therapeutics mRNA Vaccine And Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Argos Therapeutics Key News & Latest Developments
Table 34. BioNTech Company Summary
Table 35. BioNTech mRNA Vaccine And Therapeutics Product Offerings
Table 36. BioNTech mRNA Vaccine And Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. BioNTech Key News & Latest Developments
Table 38. CureVac Company Summary
Table 39. CureVac mRNA Vaccine And Therapeutics Product Offerings
Table 40. CureVac mRNA Vaccine And Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. CureVac Key News & Latest Developments
Table 42. eTheRNA Company Summary
Table 43. eTheRNA mRNA Vaccine And Therapeutics Product Offerings
Table 44. eTheRNA mRNA Vaccine And Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. eTheRNA Key News & Latest Developments
Table 46. Ethris Company Summary
Table 47. Ethris mRNA Vaccine And Therapeutics Product Offerings
Table 48. Ethris mRNA Vaccine And Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Ethris Key News & Latest Developments
Table 50. In-Cell-Art Company Summary
Table 51. In-Cell-Art mRNA Vaccine And Therapeutics Product Offerings
Table 52. In-Cell-Art mRNA Vaccine And Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. In-Cell-Art Key News & Latest Developments
Table 54. Moderna Therapeutics Company Summary
Table 55. Moderna Therapeutics mRNA Vaccine And Therapeutics Product Offerings
Table 56. Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. Moderna Therapeutics Key News & Latest Developments
Table 58. Sangamo Therapeutics Company Summary
Table 59. Sangamo Therapeutics mRNA Vaccine And Therapeutics Product Offerings
Table 60. Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 61. Sangamo Therapeutics Key News & Latest Developments
Table 62. Tiba Biotechnology Company Summary
Table 63. Tiba Biotechnology mRNA Vaccine And Therapeutics Product Offerings
Table 64. Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 65. Tiba Biotechnology Key News & Latest Developments
Table 66. Translate Bio Company Summary
Table 67. Translate Bio mRNA Vaccine And Therapeutics Product Offerings
Table 68. Translate Bio mRNA Vaccine And Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 69. Translate Bio Key News & Latest Developments
List of Figures
Figure 1. mRNA Vaccine And Therapeutics Segment by Type in 2022
Figure 2. mRNA Vaccine And Therapeutics Segment by Application in 2022
Figure 3. Global mRNA Vaccine And Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global mRNA Vaccine And Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global mRNA Vaccine And Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by mRNA Vaccine And Therapeutics Revenue in 2022
Figure 8. By Type - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
Figure 16. US mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
Figure 28. China mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa mRNA Vaccine And Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE mRNA Vaccine And Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. Argos Therapeutics mRNA Vaccine And Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BioNTech mRNA Vaccine And Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. CureVac mRNA Vaccine And Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. eTheRNA mRNA Vaccine And Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Ethris mRNA Vaccine And Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. In-Cell-Art mRNA Vaccine And Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Moderna Therapeutics mRNA Vaccine And Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sangamo Therapeutics mRNA Vaccine And Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Tiba Biotechnology mRNA Vaccine And Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Translate Bio mRNA Vaccine And Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About mRNA Vaccine And Therapeutics and Forecast Market

Leave This Empty: